What The Study Did: This study found that the use of buprenorphine for treatment of opioid use disorder in U.S. jails and prisons increased substantially during the past five years, although use is still rare among all incarcerated individuals with this disorder.
Authors: Ashish P. Thakrar, M.D., of the Veterans Affairs Medical Center in Philadelphia, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2021.38870)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.38807?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=121421
JAMA Network Open